Generation of Biologically Active Multi-Sialylated Recombinant Human EPOFc in Plants

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Castilho, Alexandra ^a   Neumann, Laura ^a   Gattinger, Pia ^a   Strasser, Richard ^a   Vorauer Uhl, Karola ^a   Sterovsky, Thomas ^b   Altmann, Friedrich ^a   Steinkellner, Herta ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b Polymun Scientific GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ERYTHROPOIETIN FUSION PROTEIN; GLYCAN; HYBRID PROTEIN; OLIGOSACCHARIDE; RECOMBINANT ERYTHROPOIETIN; SIALIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOSYNTHESIS; BRANCHING MORPHOGENESIS; CARBOHYDRATE ANALYSIS; CARBOHYDRATE TRANSPORT; COMPLEX FORMATION; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; GLYCOSYLATION; IN VITRO STUDY; INTRACELLULAR SPACE; LIQUID CHROMATOGRAPHY; MOLECULAR CLONING; MOLECULAR DYNAMICS; NICOTIANA BENTHAMIANA; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING; RESIDUE ANALYSIS; SIALYLATION; SIGNAL TRANSDUCTION; TRANSIENT EXPRESSION;

ERYTHROPOIETIN; GENE EXPRESSION; GENE ORDER; GENETIC VECTORS; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; TOBACCO;

MAMMALIA; NICOTIANA BENTHAMIANA; TETRA;

EID: 84872844872     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054836     Document Type: Article

References (50)

1. Maiese K, Chong ZZ, Li F, Shang YC, (2008) Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog Neurobiol 85: 194-213.
2. Sasaki H, Ochi N, Dell A, Fukuda M, (1988) Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometry. Biochemistry 27: 8618-8626.
3. Takeuchi M, Takasaki S, Miyazaki H, Kato T, Hoshi S, et al. (1988) Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. J Biol Chem 263: 3657-3663.
4. Dubé S, Fisher JW, Powell JS, (1988) Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. J Biol Chem 263: 17516-17521.
5. Higuchi M, Oh-eda M, Kuboniwa H, Tomonoh K, Shimonaka Y, et al. (1992) Role of sugar chains in the expression of the biological activity of human erythropoietin. J Biol Chem 267: 7703-7709.
6. Egrie JC, Browne JK, (2001) Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 16Suppl 3: 3-13.
7. Hokke CH, Bergwerff AA, Van Dedem GW, Kamerling JP, Vliegenthart JF, (1995) Structural analysis of the sialylated N- and O-linked carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Sialylation patterns and branch location of dimeric N-acetyllactosamine units. Eur J Biochem 228: 981-1008.
8. Yuen CT, Storring PL, Tiplady RJ, Izquierdo M, Wait R, et al. (2003) Relationships between the N-glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures. Br J Haematol 121: 511-526.
9. Schriebl K, Trummer E, Lattenmayer C, Weik R, Kunert R, et al. (2006) Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells. Protein Expr Purif 49: 265-275.
10. Wang MD, Yang M, Huzel N, Butler M, (2002) Erythropoietin production from CHO cells grown by continuous culture in a fluidized-bed bioreactor. Biotechnol Bioeng 77: 194-203.
11. Elliott S, Lorenzini T, Asher S, Aoki K, Brankow D, et al. (2003) Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol 21: 414-421.
12. Bragonzi A, Distefano G, Buckberry LD, Acerbis G, Foglieni C, et al. (2000) A new Chinese hamster ovary cell line expressing alpha2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins. Biochim Biophys Acta 1474: 273-282.
13. Wang Z, Park JH, Park HH, Tan W, Park TH, (2011) Enhancement of recombinant human EPO production and sialylation in chinese hamster ovary cells through Bombyx mori 30Kc19 gene expression. Biotechnol Bioeng 108: 1634-1642.
14. Bork K, Reutter W, Weidemann W, Horstkorte R, (2007) Enhanced sialylation of EPO by overexpression of UDP-GlcNAc 2-epimerase/ManAc kinase containing a sialuria mutation in CHO cells. FEBS Lett 581: 4195-4198.
15. Bitonti AJ, Dumont JA, Low SC, Peters RT, Kropp KE, et al. (2004) Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc Natl Acad Sci U S A 101: 9763-9768.
16. Davies HM, (2010) Review article: commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 8: 845-861.
17. Chung SM, Frankman EL, Tzfira T, (2005) A versatile vector system for multiple gene expression in plants. Trends Plant Sci 10: 357-361.
18. Loos A, Steinkellner H (2012) IgG-Fc glycoengineering in non-mammalian expression hosts. Arch Biochem Biophys.
19. Castilho A, Steinkellner H (2012) Glyco-engineering in plants to produce human-like N-glycan structures. Biotechnology Journal. doi:10.1002/biot.201200032.
20. Castilho A, Strasser R, Stadlmann J, Grass J, Jez J, et al. (2010) In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 285: 15923-15930.
21. Conley AJ, Mohib K, Jevnikar AM, Brandle JE, (2009) Plant recombinant erythropoietin attenuates inflammatory kidney cell injury. Plant Biotechnol J 7: 183-199.
22. Kittur FS, Hung CY, Darlington DE, Sane DC, Xie J, (2012) N-Glycosylation engineering of tobacco plants to produce asialoerythropoietin. Plant Cell Rep 31: 1233-43.
23. Parsons J, Altmann F, Arrenberg CK, Koprivova A, Beike AK, et al. (2012) Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants. Plant Biotechnol J 10: 851-61.
24. Matsumoto S, Ikura K, Ueda M, Sasaki R, (1995) Characterization of a human glycoprotein (erythropoietin) produced in cultured tobacco cells. Plant Mol Biol 27: 1163-1172.
25. Weise A, Altmann F, Rodriguez-Franco M, Sjoberg ER, BÃ{currency sign}umer W, et al. (2007) High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-t Delta-xyl-t mutant. Plant Biotechnol J 5: 389-401.
26. Castilho A, Gattinger P, Grass J, Jez J, Pabst M, et al. (2011) N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 21: 813-823.
27. Nagels B, Van Damme EJ, Callewaert N, Zabeau L, Tavernier J, et al. (2012) Biologically active, magnICON(®)-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J Biotechnol 160: 242-50.
28. Strasser R, Castilho A, Stadlmann J, Kunert R, Quendler H, et al. (2009) Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J Biol Chem 284: 20479-20485.
29. Strasser R, Stadlmann J, Schähs M, Stiegler G, Quendler H, et al. (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 6: 392-402.
30. Marillonnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y, (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat Biotechnol 23: 718-723.
31. Stadlmann J, Pabst M, Kolarich D, Kunert R, Altmann F, (2008) Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 8: 2858-2871.
32. Pabst M, Chang M, Stadlmann J, Altmann F, (2012) Glycan profiles of the 27 N-glycosylation sites of the HIV envelope protein CN54gp140. Biol Chem 393: 719-730.
33. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, et al. (1991) Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 51: 341-348.
34. Penno CA, Kawabe Y, Ito A, Kamihira M, (2010) Production of recombinant human erythropoietin/Fc fusion protein by genetically manipulated chickens. Transgenic Res 19: 187-195.
35. Im SJ, Yang SI, Yang SH, Choi DH, Choi SY, et al. (2011) Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietin. PloS one 6: e24574.
36. Recny MA, Scoble HA, Kim Y, (1987) Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin. J Biol Chem 262: 17156-17163.
37. Strasser R, Bondili JS, Vavra U, Schoberer J, Svoboda B, et al. (2007) A unique beta1,3-galactosyltransferase is indispensable for the biosynthesis of N-glycans containing Lewis a structures in Arabidopsis thaliana. Plant Cell 19: 2278-2292.
38. Morgan WT, Watkins WM, (1969) Genetic and biochemical aspects of human blood-group A-, B-, H-, Le-a- and Le-b-specificity. Br Med Bull 25: 30-34.
39. Wasley LC, Timony G, Murtha P, Stoudemire J, Dorner AJ, et al. (1991) The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Blood 77: 2624-2632.
40. Way JC, Lauder S, Brunkhorst B, Kong SM, Qi A, et al. (2005) Improvement of Fc-erythropoietin structure and pharmacokinetics by modification at a disulfide bond. Protein Eng Des Sel 18: 111-118.
41. Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, et al. (2006) Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci U S A 103: 14701-14706.
42. Taschwer M, Hackl M, Hernández Bort JA, Leitner C, Kumar N, et al. (2012) Growth, productivity and protein glycosylation in a CHO EpoFc producer cell line adapted to glutamine-free growth. J Biotechnol 157: 295-303.
43. Lombardi R, Donini M, Villani ME, Brunetti P, Fujiyama K, et al. (2012) Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation. Transgenic Res DOI10.1007/s11248-012-9587-1.
44. Hehle VK, Paul MJ, Drake PM, Ma JK, van Dolleweerd CJ, (2011) Antibody degradation in tobacco plants: a predominantly apoplastic process. BMC Biotechnol 11: 128.
45. van der Hoorn RA, (2008) Plant proteases: from phenotypes to molecular mechanisms. Annu Rev Plant Biol 59: 191-223.
46. Adamczyk M, Gebler JC, Wu J, (2000) Papain digestion of different mouse IgG subclasses as studied by electrospray mass spectrometry. J Immunol Methods 237: 95-104.
47. Dirnberger D, Steinkellner H, Abdennebi L, Remy JJ, van de Wiel D, (2001) Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants. Eur J Biochem 268: 4570-9.
48. Skibeli V, Nissen-Lie G, Torjesen P, (2001) Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 98: 3626-3634.
49. Shahrokh Z, Royle L, Saldova R, Bones J, Abrahams JL, et al. (2011) Erythropoietin produced in a human cell line (Dynepo) has significant differences in glycosylation compared with erythropoietins produced in CHO cell lines. Mol Pharm 8: 286-296.
50. Sondermann P, Huber R, Oosthuizen V, Jacob U, (2000) The 3.2-[angst] crystal structure of the human IgG1 Fc fragment-Fc[gamma]RIII complex. Nature 406: 267-273.